NM_000455.5:c.299A>C
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_000455.5(STK11):c.299A>C(p.Gln100Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q100E) has been classified as Likely benign.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | c.299A>C | p.Gln100Pro | missense_variant | Exon 2 of 10 | ENST00000326873.12 | NP_000446.1 | |
| STK11 | NM_001407255.1 | c.299A>C | p.Gln100Pro | missense_variant | Exon 2 of 9 | NP_001394184.1 | ||
| STK11 | NR_176325.1 | n.1566A>C | non_coding_transcript_exon_variant | Exon 3 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | c.299A>C | p.Gln100Pro | missense_variant | Exon 2 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.299A>C | p.Gln100Pro | missense_variant | Exon 2 of 9 | ENSP00000498804.1 | ||||
| STK11 | ENST00000593219.6 | n.*124A>C | non_coding_transcript_exon_variant | Exon 3 of 11 | 3 | ENSP00000466610.1 | ||||
| STK11 | ENST00000585748.3 | c.-74A>C | 5_prime_UTR_variant | Exon 4 of 12 | 3 | ENSP00000477641.2 | ||||
| STK11 | ENST00000593219.6 | n.*124A>C | 3_prime_UTR_variant | Exon 3 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Q100P variant (also known as c.299A>C), located in coding exon 2 of the STK11 gene, results from an A to C substitution at nucleotide position 299. The glutamine at codon 100 is replaced by proline, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at